Trine Bertelsen

467 total citations
25 papers, 341 citations indexed

About

Trine Bertelsen is a scholar working on Immunology, Dermatology and Cancer Research. According to data from OpenAlex, Trine Bertelsen has authored 25 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 11 papers in Dermatology and 7 papers in Cancer Research. Recurrent topics in Trine Bertelsen's work include Psoriasis: Treatment and Pathogenesis (17 papers), Dermatology and Skin Diseases (7 papers) and NF-κB Signaling Pathways (6 papers). Trine Bertelsen is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (17 papers), Dermatology and Skin Diseases (7 papers) and NF-κB Signaling Pathways (6 papers). Trine Bertelsen collaborates with scholars based in Denmark, Switzerland and Sweden. Trine Bertelsen's co-authors include Claus Johansen, Lars Iversen, Maike Mose, Pernille Ommen, Stephan Hailfinger, Klaus Schulze‐Osthoff, Rasmus Boye Kjellerup, Christine Huppertz, Kirsten Rønholt and Thomas Litman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Trine Bertelsen

21 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trine Bertelsen Denmark 8 255 105 97 77 76 25 341
Stefan Woehrl Switzerland 2 109 0.4× 46 0.4× 77 0.8× 46 0.6× 49 0.6× 2 230
Emilie Hendrickx Belgium 8 324 1.3× 67 0.6× 177 1.8× 17 0.2× 50 0.7× 9 410
Reiko Kamijima Japan 7 310 1.2× 68 0.6× 113 1.2× 18 0.2× 96 1.3× 10 426
S. Höxtermann Germany 11 161 0.6× 92 0.9× 98 1.0× 24 0.3× 83 1.1× 16 384
Raquel Castillo‐González Spain 9 154 0.6× 32 0.3× 37 0.4× 33 0.4× 63 0.8× 14 272
Chester Lai United Kingdom 11 221 0.9× 151 1.4× 93 1.0× 14 0.2× 65 0.9× 20 379
Matilda Bylaitė Lithuania 9 81 0.3× 70 0.7× 172 1.8× 24 0.3× 62 0.8× 14 336
R.R.M.C. Keijsers Netherlands 10 291 1.1× 56 0.5× 154 1.6× 11 0.1× 56 0.7× 15 378
Annelies Demeyer Belgium 9 253 1.0× 99 0.9× 19 0.2× 245 3.2× 176 2.3× 14 414

Countries citing papers authored by Trine Bertelsen

Since Specialization
Citations

This map shows the geographic impact of Trine Bertelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trine Bertelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trine Bertelsen more than expected).

Fields of papers citing papers by Trine Bertelsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trine Bertelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trine Bertelsen. The network helps show where Trine Bertelsen may publish in the future.

Co-authorship network of co-authors of Trine Bertelsen

This figure shows the co-authorship network connecting the top 25 collaborators of Trine Bertelsen. A scholar is included among the top collaborators of Trine Bertelsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trine Bertelsen. Trine Bertelsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertelsen, Trine, Anders Dige, Trine Bay Laurberg, et al.. (2025). Exploring associations of single nucleotide polymorphisms in ERAP1 and ERAP2 with susceptibility to multiple immune-mediated inflammatory diseases. Human Immunology. 86(4). 111338–111338.
2.
Ring, Hans Christian, Peter Theut Riis, Mads Kirchheiner Rasmussen, et al.. (2025). Hidradenitis suppurativa. Ugeskrift for Læger. 187(14). 1–8. 1 indexed citations
3.
Bertelsen, Trine, et al.. (2025). Acne. Ugeskrift for Læger. 187(14). 1–9.
4.
Bertelsen, Trine, Thomas Litman, Morten Muhlig Nielsen, et al.. (2024). Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory. International Journal of Molecular Sciences. 25(11). 6086–6086. 3 indexed citations
5.
Winther, Ole, Hans B. Lomholt, Henrik Lorentzen, et al.. (2024). Physician Level Assessment of Hirsute Women and of Their Eligibility for Laser Treatment With Deep Learning. Lasers in Surgery and Medicine. 57(1). 80–87. 1 indexed citations
6.
Bertelsen, Trine, et al.. (2024). ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgaris. Clinical and Experimental Dermatology. 49(10). 1171–1178. 3 indexed citations
7.
Bertelsen, Trine, et al.. (2024). Systemic treatments for psoriasis. Ugeskrift for Læger. 186(46). 1–7. 1 indexed citations
8.
Rasmussen, Mads Kirchheiner, Trine Bertelsen, Tomas Norman Dam, et al.. (2023). Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study. Journal of the American Academy of Dermatology. 88(6). 1378–1381. 5 indexed citations
9.
Bertelsen, Trine, Alexander Egeberg, Lone Skov, et al.. (2023). Drug survival of biologic therapies for palmoplantar pustulosis: A nationwide study. Journal of the European Academy of Dermatology and Venereology. 38(2). 332–339. 1 indexed citations
10.
Loft, Nikolai, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.. (2023). Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study. Acta Dermato Venereologica. 103. adv12616–adv12616. 3 indexed citations
11.
Bertelsen, Trine, Henrik Hager, Lars Iversen, et al.. (2022). Global circRNA expression changes predate clinical and histological improvements of psoriasis patients upon secukinumab treatment. PLoS ONE. 17(9). e0275219–e0275219. 7 indexed citations
12.
Bertelsen, Trine, Lars Iversen, & Claus Johansen. (2021). I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes. Annals of Dermatology. 33(2). 122–122. 4 indexed citations
13.
Bertelsen, Trine, Thomas Litman, Christine Huppertz, et al.. (2019). IκBζ is a key player in the antipsoriatic effects of secukinumab. Journal of Allergy and Clinical Immunology. 145(1). 379–390. 36 indexed citations
14.
Johansen, Claus, Maike Mose, Trine Bertelsen, et al.. (2017). STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes. PLoS ONE. 12(5). e0176994–e0176994. 37 indexed citations
15.
Johansen, Claus, et al.. (2016). 344 STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes. Journal of Investigative Dermatology. 136(9). S219–S219. 7 indexed citations
16.
Bertelsen, Trine, et al.. (2016). 346 IL-17F regulates psoriasis-associated genes through IκBζ. Journal of Investigative Dermatology. 136(9). S220–S220. 2 indexed citations
17.
Johansen, Claus, et al.. (2016). Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ. Journal of Investigative Dermatology. 136(8). 1608–1616. 44 indexed citations
18.
Bertelsen, Trine & Lars Iversen. (2015). Systemic Treatment of Psoriasis in Children. Journal of Clinical & Experimental Dermatology Research. 6(6). 1 indexed citations
19.
Bertelsen, Trine & Karsten Fogh. (2013). [Cancer unmasked or provoked by immunosuppressive therapy].. PubMed. 175(49A). V04130215–V04130215.
20.
Bertelsen, Trine, Lars Iversen, Jette Lindorff Riis, et al.. (2010). The role of mitogen‐ and stress‐activated protein kinase 1 and 2 in chronic skin inflammation in mice. Experimental Dermatology. 20(2). 140–145. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026